[CYCC] QoQ Quarter Result on 31-Mar-2010 [#Q1]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
19-May-2010
Financial Year
2010
Quarter
31-Mar-2010 [#Q1]
Profit Trend
QoQ- -17.85%
YoY- -0.95%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
Revenue 138 159 119 271 187 230 266 -35.35%
PBT -3,323 -3,950 -4,163 -5,244 -4,489 -3,329 -7,278 -40.62%
Tax -151 -143 -230 -133 -152 -205 -233 -25.05%
NP -3,172 -3,807 -3,933 -5,111 -4,337 -3,124 -7,045 -41.16%
Tax Rate - - - - - - - -
Total Cost 3,310 3,966 4,052 5,382 4,524 3,354 7,311 -40.95%
Ratio Analysis
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
NP Margin -2,298.55 -2,394.34 -3,305.04 -1,885.98 -2,319.25 -1,358.26 -2,648.50 -8.99%
Per Share
31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 CAGR
EPS -115.84 -172.72 -180.70 -270.70 -229.70 -226.51 -579.26 -65.70%
EPS Diluted -114.43 -172.72 -180.70 -270.70 -229.70 -226.51 -579.26 -65.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.